Krsnaa Diagnostics Ltd - Stock Valuation and Financial Performance

BSE: 543328 | NSE: KRSNAA | Hospital & Healthcare Services | Small Cap

Krsnaa Diagnostics Share Price

595.40 -1.95 -0.33%
as on 18-May'24 12:50

DeciZen - make an informed investing decision on Krsnaa Diagnostics

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Krsnaa Diagnostics stock performance -

mw4me loader
P/E Ratio (SA):
37.13
Market Cap:
1,928.8 Cr.
52-wk low:
448.7
52-wk high:
788.6

Is Krsnaa Diagnostics Ltd an attractive stock to invest in?

1. Is Krsnaa Diagnostics Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Krsnaa Diagnostics Ltd is a average quality company.

2. Is Krsnaa Diagnostics Ltd undervalued or overvalued?

The key valuation ratios of Krsnaa Diagnostics Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Krsnaa Diagnostics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Krsnaa Diagnostics Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Krsnaa Diagnostics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Krsnaa Diagnostics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 6.2%16.9%49.3%81.7%14.1%9.2%-
Value Creation
Index
-0.60.22.54.80.0-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 90.6209258396455464547
Sales YoY Gr.-131%23.5%53.4%14.7%2%-
Adj EPS 5.68.511.6142.622.620.216.1
YoY Gr.-52.3%35.9%1130.7%-84.2%-10.5%-
BVPS (₹) 15.1-96.8-205.3-8.7218.1235.6239.9
Adj Net
Profit
5.88.81218570.963.452
Cash Flow from Ops. 52.558.337.811912975.5-
Debt/CF from Ops. 1.92.96.120.30.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA38.7%21.6%2%
Adj EPS NA29.2%20.3%-10.5%
BVPSNA73.3%NA8.1%
Share Price - - - 11.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
7.2-404.7-8.51062.215.48.96.8
Op. Profit
Mgn %
33.727.724.323.829.626.823.4
Net Profit
Mgn %
6.44.24.646.715.613.79.5
Debt to
Equity
1.3-2-1.210.10-
Working Cap
Days
0159166124146207110
Cash Conv.
Cycle
038-11-40-1856

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 21.55%

Net Profit is growing at healthy rate in last 3 years 20.32%

Sales growth is good in last 4 quarters at 19.60%

Return on Equity has declined versus last 3 years average to 6.80%

Latest Financials - Krsnaa Diagnostics Ltd.

Standalone Consolidated
TTM EPS (₹) 16.1 17.7
TTM Sales (₹ Cr.) 547 587
BVPS (₹.) 239.9 238.1
Reserves (₹ Cr.) 758 753
P/BV 2.49 2.51
PE 37.13 33.82
From the Market
52 Week Low / High (₹) 448.70 / 788.60
All Time Low / High (₹) 354.00 / 1099.50
Market Cap (₹ Cr.) 1,929
Equity (₹ Cr.) 16.1
Face Value (₹) 5
Industry PE 83.5

Management X-Ray of Krsnaa Diagnostics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Krsnaa Diagnostics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales91209258396455464
Operating Expenses 61247373303320340
Manufacturing Costs157695127134101
Material Costs111728846074
Employee Cost 161823305366
Other Costs 20136227627399
Operating Profit 29-38-11494135124
Operating Profit Margin (%) 32.2%-18.0%-44.2%23.7%29.6%26.8%
Other Income 15132651519
Interest 8202526188
Depreciation 172632374154
Exceptional Items 000000
Profit Before Tax 5-78-1582959082
Tax 1-20-461111919
Profit After Tax 5-58-1121857164
PAT Margin (%) 5.4%-27.7%-43.3%46.6%15.5%13.7%
Adjusted EPS (₹)4.7-56.2-108.0142.422.520.2
Dividend Payout Ratio (%)0%0%0%0%11%14%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 81-85-197231685740
Share Capital 7020202491616
Reserves 10-105-217-18669724
Minority Interest000000
Debt831462152033324
Long Term Debt56921231683324
Short Term Debt2754923500
Trade Payables164238837659
Others Liabilities 92383482928386
Total Liabilities 271485538609877909

Fixed Assets

Gross Block191264308377491627
Accumulated Depreciation39413268106156
Net Fixed Assets153223275309386471
CWIP 3542942825
Investments 000000
Inventories2457925
Trade Receivables295661755975
Cash Equivalents 9112127153242108
Others Assets43486061153205
Total Assets 271485538609877909

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 52583811912975
PBT 5-78-1582959082
Adjustment 28140226-1994945
Changes in Working Capital 213-1930-3-38
Tax Paid -2-7-10-8-7-13
Cash Flow From Investing Activity -91-199-77-67-241-109
Capex -88-100-772-131-135
Net Investments -3-101-7-77-12616
Others 01771710
Cash Flow From Financing Activity 41124620176-33
Net Proceeds from Shares 00014000
Net Proceeds from Borrowing 3544300-159-9
Interest Paid -8-16-24-23-16-5
Dividend Paid 00000-8
Others 1496043-48-11
Net Cash Flow 3-17-337164-66
PARTICULARSMar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)31.2N/AN/A0218.92
ROCE (%)7.24N/AN/A129.0918.1511.96
Asset Turnover Ratio0.330.550.510.690.610.52
PAT to CFO Conversion(x)10.4N/AN/A0.641.821.17
Working Capital Days
Receivable Days1157483635453
Inventory Days8576713
Payable Days543604525265484334

Krsnaa Diagnostics Ltd Stock News

Krsnaa Diagnostics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Krsnaa Diagnostics on 18-May-2024 12:50 is ₹595.4.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-May-2024 12:50 the market cap of Krsnaa Diagnostics stood at ₹1,928.8.
The latest P/E ratio of Krsnaa Diagnostics as of 18-May-2024 12:50 is 37.13.
The latest P/B ratio of Krsnaa Diagnostics as of 18-May-2024 12:50 is 2.49.
The 52-week high of Krsnaa Diagnostics is ₹788.6 and the 52-week low is ₹448.7.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krsnaa Diagnostics is ₹546.5 ( Cr.) .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.

The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.

Business area of the company

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Key awards, accreditations or recognitions

  • 2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
  • 2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
  • 2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
  • 2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
  • 2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
  • 2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.

Major events and milestones

  • 2011: Incorporation of the company with two radiology centres.
  • 2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
  • 2016: Investment by Somerset and Kitara in the Company.
  • 2017: Completed installation of 50 centres in four states.
  • 2018: Expanded operations across 13 states.
  • 2019: Received accreditation from NABH for a centre in Madhya Pradesh.
  • 2019: Investment by Phi Capital in the company.
  • 2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
  • 2020: Expanded to over 1,500 centres across India.
  • 2020: Received accreditation from NABL for certain centres in Rajasthan.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.